The SEC is going after another individual over an alleged insider trading scheme related to information stolen from a Covington & Burling attorney’s computer.
The agency on Tuesday said Philip Markin bought Pandion Therapeutics Inc. stock before the biotechnology company was acquired by
Philip Markin knew or was reckless in not knowing that the information was material and nonpublic, the Securities and Exchange Commission said in a ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.